iShares Broad USD Investment Grade Corporate Bond ETF (USIG)
Live price chart, market sentiment, and community perspectives for iShares Broad USD Investment Grade Corporate Bond ETF (NASDAQ: USIG).
Live price chart, market sentiment, and community perspectives for iShares Broad USD Investment Grade Corporate Bond ETF (NASDAQ: USIG).
Order flow on USIG suggests systematic accumulation by long-only institutional accounts during yesterday's dip.
Looking at the risk metrics for USIG, the fund maintains a Morningstar conservative risk score profile with a 3-year standard deviation of 5.92 and a Sharpe ratio of 0.15. Total return over the trailing 3-year period stands at 5.53%. Even though the ETF recently touched a new 1-year low with heavy volume exceeding 1.06 million shares during mid-day trading, its underlying asset structure holding investment-grade corporate bonds of U.S. and non-U.S. issuers provides institutional-grade stability that quantitative models continue to evaluate.
On our desk, we are closely monitoring USIG as it trades down to fresh 52-week lows around $50.13 to $50.15. While the technical momentum looks heavy—with the price lingering beneath both the 50-day moving average of $50.77 and the 200-day moving average of $51.23—the fundamental yield story has improved. The fund recently boosted its monthly dividend to $0.2064, translating to an annualized yield of about 4.9%. Market sentiment reflects cautious observation of these price levels against macroeconomic fixed-income headwinds.
In evaluating the operational framework of USIG for our quantitative strategies, we note its adherence to the ICE BofA US Corporate Index. The fund invests at least 80% of its assets in index components and at least 90% in fixed income securities of the types included in the index. When analyzing execution protocols during periods where the ETF hits new 52-week lows, liquidity metrics like the 798K to 1M+ share volumes become critical for managing tracking error and evaluating broader market participation.
Explore plasma cleansing, somatic organ swaps, and BCI.